Home LiteratureArticle Details
PMID: 22682000 Published · epublish English Journal Article

Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia.

BMC pediatrics ·Vol. 12 ·2012-06-08 ·Pages 63

Botet F, Figueras-Aloy J, Miracle-Echegoyen X, Rodríguez-Miguélez JM, Salvia-Roiges MD, Carbonell-Estrany X

Abstract

The aim of this study was to analyze the evolution from 1997 to 2009 of survival without significant (moderate and severe) bronchopulmonary dysplasia (SWsBPD) in extremely-low-birth-weight (ELBW) infants and to determine the influence of changes in resuscitation, nutrition and mechanical ventilation on the survival rate. In this study, 415 premature infants with birth weights below 1000 g (ELBW) were divided into three chronological subgroups: 1997 to 2000 (n = 65), 2001 to 2005 (n = 178) and 2006 to 2009 (n = 172).Between 1997 and 2000, respiratory resuscitation in the delivery room was performed via a bag and mask (Ambu®, Ballerup, Sweden) with 40-50% oxygen. If this procedure was not effective, oral endotracheal intubation was always performed. Pulse oximetry was never used. Starting on January 1, 2001, a change in the delivery room respiratory policy was established for ELBW infants. Oxygenation and heart rate were monitored using a pulse oximeter (Nellcor®) attached to the newborn's right hand. If resuscitation was required, ventilation was performed using a face mask, and intermittent positive pressure was controlled via a ventilator (Babylog2, Drägger). In 2001, a policy of aggressive nutrition was also initiated with the early provision of parenteral amino acids. We used standardized parenteral nutrition to feed ELBW infants during the first 12-24 hours of life. Lipids were given on the first day. The glucose concentration administered was increased by 1 mg/kg/minute each day until levels reached 8 mg/kg/minute. Enteral nutrition was started with trophic feeding of milk. In 2006, volume guarantee treatment was instituted and administered together with synchronized intermittent mandatory ventilation (SIMV + VG). The complications of prematurity were treated similarly throughout the study period. Patent ductus arteriosus was only treated when hemodynamically significant. Surgical closure of the patent ductus arteriosus was performed when two courses of indomethacin or ibuprofen were not sufficient to close it.Mild BPD were defined by a supplemental oxygen requirement at 28 days of life and moderate BPD if breathing room air or a need for <30% oxygen at 36 weeks postmenstrual age or discharge from the NICU, whichever came first. Severe BPD was defined by a supplemental oxygen requirement at 28 days of life and a need for greater than or equal to 30% oxygen use and/or positive pressure support (IPPV or nCPAP) at 36 weeks postmenstrual age or discharge, whichever came first. Moderate and severe BPD have been considered together as "significant BPD". The goal of pulse oximetry was to maintain a hemoglobin saturation of between 88% and 93%. Patients were considered to not need oxygen supplementation when it could be permanently withdrawn. The distribution of the variables was not normal based on a Kolmogorov-Smirnov test (p < 0.05 in all cases). Therefore, quantitative variables were expressed as the median and interquartile range (IQR; 25th-75th percentile). Statistical analysis of the data was performed using nonparametric techniques (Kruskal-Wallis test and Mann-Whitney U test). A chi-square analysis was used to analyze qualitative variables. Potential confounding variables were those possibly related to BPD in survivors (p between 0.05 and 0.3 in univariate analysis). Logistic regression analysis was performed with variables related to BPD in survivors (p < 0.05) and potential confounding variables. The forward stepwise method adjusted for confounding factors was used to select the variables, and the enter method using selected variables was used to obtain the odds ratios. There was an increase in the rate of SWsBPD (1997 to 2000: 58.5%; 2001 to 2005: 74.2%; and 2006 to 2009: 75.0%; p = 0.032). In survivors, the occurrence of significant BPD decreased after 2001 (9.5% vs. 2.3%; p = 0.013). The factors associated with improved SWsBPD were delivery by caesarean section, a reduced endotracheal intubation rate and a reduced duration of mechanical ventilation.While the mortality of ELBW infants has not changed since 2001, the frequency of SWsBPD has significantly increased (75.0%) in association with increased caesarean sections and reductions in the endotracheal intubation rate, as well as the duration of mechanical ventilation.

MeSH Terms
Bronchopulmonary Dysplasia/mortality Female Humans Infant, Extremely Low Birth Weight Infant, Newborn Male Severity of Illness Index Survival Rate/trends Time Factors
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Botet Francesc
Neonatology Service, Hospital Clínic de Barcelona, Sabino de Arana 1, 08028 Barcelona, Spain. [email protected]
Figueras-Aloy Josep
Miracle-Echegoyen Xavier
Rodríguez-Miguélez José Manuel
Salvia-Roiges Maria Dolors
Carbonell-Estrany Xavier
References (26)
26 references, click to expand
  1. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.
    N Engl J Med. 1967 Feb 16;276(7):357-68 PMID: 5334613
  2. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia.
    J Perinatol. 2003 Sep;23(6):451-6 PMID: 13679930
  3. Randomized study of nasal continuous positive airway pressure in the preterm infant with respiratory distress syndrome.
    Acta Paediatr. 2003 Oct;92(10):1170-4 PMID: 14632333
  4. State of the art in conventional mechanical ventilation.
    J Perinatol. 2009 Apr;29(4):262-75 PMID: 19242486
  5. Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants.
    Arch Dis Child Fetal Neonatal Ed. 1997 Jul;77(1):F4-11 PMID: 9279175
  6. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial.
    J Perinatol. 2005 Nov;25(11):703-8 PMID: 16163369
  7. Effect of maternal clinical chorioamnionitis on neonatal morbidity in very-low birthweight infants: a case-control study.
    J Perinat Med. 2010 May;38(3):269-73 PMID: 20121532
  8. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation.
    Pediatrics. 2004 Jun;113(6):e560-3 PMID: 15173537
  9. Current perspectives on the prevention and management of chronic lung disease in preterm infants.
    Paediatr Drugs. 2003;5(7):463-80 PMID: 12837119
  10. Nasal CPAP or intubation at birth for very preterm infants.
    N Engl J Med. 2008 Feb 14;358(7):700-8 PMID: 18272893
  11. Amino acid administration to premature infants directly after birth.
    J Pediatr. 2005 Oct;147(4):457-61 PMID: 16227030
  12. Bronchopulmonary dysplasia: definitions and long-term respiratory outcome.
    Early Hum Dev. 2009 Oct;85(10 Suppl):S1-3 PMID: 19793629
  13. Volume guarantee versus high-frequency ventilation: lung inflammation in preterm infants.
    Arch Dis Child Fetal Neonatal Ed. 2008 Jul;93(4):F252-6 PMID: 17405870
  14. What is new in ventilation strategies for the neonate?
    Eur J Pediatr. 2007 Oct;166(10):991-6 PMID: 17541770
  15. To tube or not to tube babies with respiratory distress syndrome.
    J Perinatol. 2009 May;29 Suppl 2:S68-72 PMID: 19399013
  16. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants.
    Cochrane Database Syst Rev. 2003;(2):CD000143 PMID: 12804388
  17. Early CPAP versus surfactant in extremely preterm infants.
    N Engl J Med. 2010 May 27;362(21):1970-9 PMID: 20472939
  18. Bronchopulmonary dysplasia.
    Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9 PMID: 11401896
  19. Impact of a physiologic definition on bronchopulmonary dysplasia rates.
    Pediatrics. 2004 Nov;114(5):1305-11 PMID: 15520112
  20. Aggressive nutrition of the very low birthweight infant.
    Clin Perinatol. 2002 Jun;29(2):225-44 PMID: 12168239
  21. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network.
    Pediatrics. 2000 Jun;105(6):1194-201 PMID: 10835057
  22. Iatrogenic malnutrition in neonatal intensive care units: urgent need to modify practice.
    JPEN J Parenter Enteral Nutr. 2008 Mar-Apr;32(2):140-4 PMID: 18407906
  23. Chronic lung disease after premature birth.
    N Engl J Med. 2007 Nov 8;357(19):1946-55 PMID: 17989387
  24. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome.
    J Pediatr. 2006 Mar;148(3):300-305 PMID: 16615955
  25. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.
    Acta Paediatr. 2009 Sep;98(9):1400-8 PMID: 19572989
  26. Pathology of bronchopulmonary dysplasia.
    Semin Perinatol. 2006 Aug;30(4):179-84 PMID: 16860157
Article Info
Journal
BMC pediatrics
Abbr.
BMC Pediatr
ISSN
1471-2431
Published
2012-06-08
Epub
2012-00-08
Pages
63
Language
English
Region
England
NLM ID
100967804
PMCID
PMC3507706
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]